六個中低收入國家國家人類乳頭瘤病毒(HPV)疫苗接種規劃的成本與實施背景
研究在埃塞俄比亞、圭亞那、盧旺達、塞內加爾、斯里蘭卡和烏干達六國國家HPV疫苗規劃引入後年份,採用實施性研究與微觀成本法回顧性收集基層與國家級數據,估算每劑遞送成本:財務成本每劑0.27至3.32美元,經濟成本每劑3.09至17.20美元;部分國家成本低於引入時。
要点
- 六國53%至99%的HPV疫苗接種場次在學校開展。
- 各國衛生機構年均經濟成本1207至3190美元,國家級7657至304278美元。
- 各國每劑財務成本0.27至3.32美元,經濟成本3.09至17.20美元。
核心结论
- 部分研究國家的HPV疫苗接種成本低於引入時。
- 各國HPV疫苗接種活動內容與接種劑次數存在差異,影響成本估算。
研究设计与样本
- 採用實施性研究與微觀成本法,回顧性收集埃塞俄比亞、圭亞那、盧旺達、塞內加爾、斯里蘭卡和烏干達六國國家HPV疫苗接種規劃活動的原始數據。
- 數據來自國家級及抽樣的下級行政辦公室和衛生機構。
- 成本從衛生系統角度估算,以2019年美元報告。
主要发现
- 各研究國家53%至99%的HPV疫苗接種場次在學校開展。
- 各國衛生機構年均經濟成本為1207至3190美元,國家級年均經濟成本為7657至304278美元。
- 各國衛生機構年均接種HPV疫苗劑次為162至761劑。
- 各研究國家每劑財務成本為0.27至3.32美元,每劑經濟成本為3.09至17.20美元。
- 各國規劃活動的強度與頻率及所用資源存在差異。
局限性
- 原文未報告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: There are concerns from immunization program planners about high delivery costs for human papillomavirus (HPV) vaccine. Most prior research evaluated costs of HPV vaccine delivery during demonstration projects or at introduction, showing relatively high costs, which may not reflect the costs beyond the pilot or introduction years. This study sought to understand the operational context and estimate delivery costs for HPV vaccine in six national programs, beyond their introduction years. METHODS: Operational research and microcosting methods were used to retrospectively collect primary data on HPV vaccination program activities in Ethiopia, Guyana, Rwanda, Senegal, Sri Lanka, and Uganda. Data were collected from the national level and a sample of subnational administrative offices and health facilities. Operational data collected were tabulated as percentages and frequencies. Financial costs (monetary outlays) and economic costs (financial plus opportunity costs) were estimated, as was the cost per HPV vaccine dose delivered. Costing was done from the health system perspective and reported in 2019 United States dollars (US$). RESULTS: Across the study countries, between 53 % and 99 % of HPV vaccination sessions were conducted in schools. Differences were observed in intensity and frequency with which program activities were conducted and resources used. Mean annual economic costs at health facilities in each country ranged from $1,207 to $3,190, while at the national level these ranged from $7,657 to $304,278. Mean annual HPV vaccine doses delivered per health facility in each country ranged from 162 to 761. Mean financial costs per dose per study country ranged from $0.27 to $3.32, while the economic cost per dose ranged from $3.09 to $17.20. CONCLUSION: HPV vaccine delivery costs were lower than at introduction in some study countries. There were differences in the activities carried out for HPV vaccine delivery and the number of doses delivered, impacting the cost estimates.
引用
- Mvundura M, Slavkovsky R, Debellut F, et al. Cost and operational context for national human papillomavirus (HPV) vaccine delivery in six low- and middle-income countries. Vaccine. 2023. PMID: 37949752. doi:10.1016/j.vaccine.2023.11.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。